Catalyst Wire Dossier Catalyst Wire Dossier

Ganciclovir ophthalmic solution 2%

ganciclovir
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ganciclovir ophthalmic solution 2%, covering 2025-05-18 to 2025-05-18. Get the full timeline:

Most recent: Clinical Trial Update: Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis [Phase 4]

See pricing